By Lana Birbrair ( March 28, 2012, 4:20 PM EDT) -- Months after warning that high doses of Forest Laboratories Inc.'s antidepressant Celexa could cause a potentially fatal irregular heartbeat, the U.S. Food and Drug Administration announced Wednesday that it had revised its recommendations to clarify how at-risk patients could still benefit from the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.